已收盘 12-19 16:00:00 美东时间
+0.030
+0.13%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
JP Morgan analyst Lilia-Celine Lozada maintains Envista Holdings (NYSE:NVST) with a Neutral and raises the price target from $20 to $22.
12-16 23:41
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
12-10 10:33
Barclays analyst Glen Santangelo initiates coverage on Envista Holdings (NYSE:NVST) with a Overweight rating and announces Price Target of $24.
12-09 23:44
The healthcare sector’s slump had created opportunities for stock-pickers rather than broad sector gains, Goldman Sachs strategist David Kostin said. Healthcare (XLV) has lagged the S&P 500 (SPY) (IVV...
11-11 00:19
Envista Holdings shares are trading higher after the company reported better-th...
10-30 20:51
Outlook:The Company is updating its guidance for the full year 2025: Current 2025 GuidancePrior 2025 GuidanceCore Sales Growth~4%3% to 4%Adjusted EBITDA Margin~14%~14%Adjusted Diluted Earnings Per Share$1.10 to
10-30 15:42
Envista Holdings (NYSE:NVST) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.28 by 15.52 percent. This is a 166.67 percent increase over earnings of $0.12 per share from the
10-30 15:36
Integer Holdings (NYSE:ITGR) is preparing to release its quarterly earnings on ...
10-23 03:03
Envista Holdings Corp's (NYSE:NVST) short interest as a percent of float has fa...
10-18 04:00